Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roquette To Inject 60 Million Yuan Into Guangxi Nanning Chemical Pharmaceutical

This article was originally published in PharmAsia News

Executive Summary

Guangxi Nanning Chemical Pharmaceutical, one of China's largest medical mannitol producers, has confirmed that French Roquette is increasing its share acquisition. According to the exclusive restructuring agreement, Roquette will raise its Nanning Chemical stake to 67 percent. It will pump in an initial investment of 60 million yuan in 2008 to revamp the existing production line and set up new hexahydric alcohol and crystal sorbitol lines to double the current annual output of 8,000 and 3,000 tons respectively. A Nanning Chemical source revealed that the company plans to establish a medical mannitol production base after the reorganization, but no details are yet available. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel